-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Emerging therapies for the treatment of uveitis: clinical trial observations
Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for the treatment of uveitis: clinical trial observations
Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for the treatment of uveitis: clinical trial observations
Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for the treatment of uveitis: clinical trial observations
Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for the treatment of uveitis: clinical trial observations
Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for the treatment of uveitis: clinical trial observations
Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for the treatment of uveitis: clinical trial observations
Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for the treatment of uveitis: clinical trial observations
Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation